<DOC>
	<DOCNO>NCT01510522</DOCNO>
	<brief_summary>This open-label , multicenter , two-arm , parallel , randomize phase 4 study compare compliance diabetes type 2 patient treated Glucophage sachet versus patient treated Glucophage tablet .</brief_summary>
	<brief_title>Evaluate Adherence Treatment With Glucophage Sachets Versus Tablets Diabetes Type 2 Patients Previously Treated With Metformin Tablets</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diabetes mellitus type 2 diagnose ( Baseline Glycemia &gt; 7,0 mmol/L ( 126 mg/dL ) overload Glycemia &gt; 11,0 mmol/L ( 198 mg/dL ) On treatment metformin tablet Patients least 2 treated comorbidities Established dose Metformin &gt; 1.700 mg/day Age &gt; 18 year old Given inform consent Patients able take medication orally According Summary Product Characteristics ( SmPC ) Participating another clinical trial 30 day prior randomization Any illness medical psychiatric condition , severe uncontrolled could interfere patient 's participation assessment study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Glucophage</keyword>
	<keyword>Metformin</keyword>
	<keyword>sachet</keyword>
	<keyword>tablet</keyword>
</DOC>